Peripheral Orbital Atherectomy System With GlideAssist® Introduced in Europe

This Week’s News in Review

This Week's News in Review! Medical Device News Magazine keeps our readers up-to-date on breaking industry news! Learn how Medical Device News Magazine can help...

New Research Shows Nearly Half of Elderly Suffer Decreased Mobility During Lockdown

In a survey of UK adults with parents over the age of 75, while over half (52%) of respondents remain worried about their parents catching Covid, 48 percent are concerned about parental loneliness, and 46 percent about their parents falling alone and not being able to get up or get help. This figure remained high even among those whose parents are in care homes, with 37% of respondents still most concerned about parents falling over.

American College of Cardiology Names Ravee Kurian COO/CFO

Kurian comes to ACC following a 20-year stint at Publicis Sapient, a leading technology and communications consultancy, where he led critical and sensitive digital transformation initiatives for Fortune 500 and U.S. federal clients.

Cardiovascular Systems, Inc. announced today that the first patient in Europe has been treated with its Stealth 360®Peripheral Orbital Atherectomy System (OAS) 1.25mm Micro Crown with GlideAssist® (1.25 Micro Crown).

The 1.25 Micro Crown is designed with flexibility for tortuous vessels and tight bends below the knee. The GlideAssist feature enables the crown to spin at a slow speed of 5K rpm, facilitating tracking and smoother movement to access diffuse, calcified lesions below the knee.

Dr. Michael Lichtenberg, Chief Physician, Clinic for Angiology, Hochsauerland Hospital, Arnsberg, Germany, successfully treated the first peripheral patient with the 1.25 Micro Crown.

Dr. Lichtenberg said, “CSI’s new Stealth OAS 1.25 Micro Crown with GlideAssist is a welcome addition to my toolbox for treating challenging critical limb ischemia, or CLI, cases. In particular, the device’s dual mechanism of action of differential sanding and pulsatile forces will be instrumental in the treatment of the challenging calcified lesions I often see in lesions below the knee.”

Scott Ward, Chairman, President and Chief Executive Officer of CSI, said, “With our distribution partner, OrbusNeich®, we are excited to introduce the 1.25 Micro Crown in Germany. One million German patients suffer from CLI, a severe condition that can result in severe pain, tissue damage and loss of limbs. The 1.25 Micro Crown provides physicians with a minimally invasive therapy to access and effectively treat this condition by modifying calcified lesions below the knee and restoring blood flow to the foot.”

spot_img

DON'T MISS

Dr Jonathan Slotkin Appointed to Peer Well Board of Directors

Alongside the appointment, PeerWell is launching its new clinical practice, PeerWell Health.

Zimmer Biomet Announces New Appointments to Executive Leadership Team

Wilfred van Zuilen Appointed as President of Europe, Middle East and Africa. Nitin Goyal, M.D. Appointed to Newly Created Role of Chief Science, Technology and Innovation Officer.

Subscribe to Medical Device News Magazine here.

Related Articles